全球生物加工技术市场规模、份额、趋势和成长分析报告（2026-2034年）

预计生物加工技术市场将从 2025 年的 409.6 亿美元成长到 2034 年的 879.5 亿美元，2026 年至 2034 年的复合年增长率为 8.86%。

由于生物製药需求不断增长以及对高效生产製程的需求日益迫切，生物加工技术市场正经历显着增长。生物加工技术是指用于开发和生产生物製品（例如疫苗、单株抗体和重组蛋白）的一系列技术。随着全球生物製药产业的持续扩张，对能够提高生产效率和降低成本的先进生物加工解决方案的需求也日益增长。随着企业增加对生物加工技术的投资以提高生产效率和产品质量，预计该市场将稳步成长。

此外，生物加工技术的进步正在推动市场创新。连续生产流程、一次性技术和自动化解决方案的发展正在改变生物製药的生产方式。这些创新不仅提高了效率，还降低了污染风险，并增强了可扩展性。随着生物加工技术市场的不断发展，持续的研发工作将在拓展解决方案范围、满足生物製药产业多样化需求方面发挥关键作用。

此外，对个人化医疗和标靶治疗日益增长的关注也在塑造生物加工技术的发展趋势。随着医疗机构为每位患者寻求更个人化的治疗方案，对灵活且适应性强的生物加工解决方案的需求预计将进一步成长。这一趋势在细胞和基因治疗领域尤其重要，因为该领域需要先进的生物製程技术来生产客製化的生物製品。随着生物加工技术市场的持续成长，技术进步、监管合规以及对个人化医疗的追求三者融合，将在塑造其未来发展轨迹方面发挥关键作用，确保生物製药公司能够满足不断变化的医疗保健环境的需求。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球生物製程技术市场（依产品划分）

• 市场分析、洞察与预测
• 耗材及配件（培养基、试剂等）
• 设备（生物製程分析仪、血液气体分析仪、渗透压计、细胞计数器、培养箱、生物反应器、其他（离心机、光强度、过滤设备））

5. 全球生物工艺技术市场（按应用划分）

• 市场分析、洞察与预测
• 初次手术
• 抗生素
• 重组蛋白
• 单株抗体
• 生物相似药

6. 全球生物工艺技术市场（依最终用户划分）

• 市场分析、洞察与预测
• 生物製药公司
• 契约製造组织
• CRO（受託研究机构）
• 食品和饲料业
• 学术研究机构

7. 全球生物工艺技术市场（按地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Siemens Healthineers
  • GE Healthcare
  • Sartorius AG
  • Becton, Dickinson And Company
  • Danaher Corporation
  • Eppendorf AG
  • Lonza
  • Advanced Instruments
  • Nova Biomedical
  • F. Hoffmann-La Roche Ltd

The Bioprocess Technology Market size is expected to reach USD 87.95 Billion in 2034 from USD 40.96 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The bioprocess technology market is experiencing significant growth, driven by the increasing demand for biopharmaceuticals and the need for efficient production processes. Bioprocess technology encompasses a range of techniques used to develop and manufacture biological products, including vaccines, monoclonal antibodies, and recombinant proteins. As the global biopharmaceutical industry continues to expand, the demand for advanced bioprocessing solutions that enhance productivity and reduce costs is on the rise. Companies are increasingly investing in bioprocess technology to streamline their manufacturing operations and improve product quality, positioning this market for robust expansion.

Moreover, advancements in bioprocess technology are driving innovation within the market. The development of continuous manufacturing processes, single-use technologies, and automation solutions is transforming the way biopharmaceuticals are produced. These innovations not only enhance efficiency but also reduce the risk of contamination and improve scalability. As the bioprocess technology market continues to evolve, ongoing research and development efforts will play a crucial role in expanding the range of solutions available to meet the diverse needs of the biopharmaceutical industry.

Additionally, the growing emphasis on personalized medicine and targeted therapies is shaping the bioprocess technology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable bioprocessing solutions is likely to rise. This trend is particularly relevant in the context of cell and gene therapies, where the production of customized biological products requires advanced bioprocessing techniques. As the bioprocess technology market continues to grow, the convergence of technological advancements, regulatory compliance, and the push for personalized medicine will play a pivotal role in shaping its future trajectory, ensuring that biopharmaceutical companies can meet the evolving demands of the healthcare landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables & Accessories (Culture Media, Reagents, Others)
• Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration))

By Application

• Primary Surgical
• Antibiotics
• Recombinant Proteins
• Monoclonal Antibodies
• Biosimilar

By End-user

• Biopharmaceutical Companies
• Contract Manufacturing Organization
• Contract Research Organization
• Food & Feed Industry
• Academic Research Organization

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Siemens Healthineers, GE Healthcare, Sartorius AG, Becton, Dickinson And Company, Danaher Corporation, Eppendorf AG, Lonza, Advanced Instruments, Nova Biomedical, F HoffmannLa Roche Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables & Accessories (Culture Media, Reagents, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration)) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Primary Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Recombinant Proteins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Biosimilar Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Contract Manufacturing Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Food & Feed Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Academic Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPROCESS TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOPROCESS TECHNOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Siemens Healthineers
  • 9.2.3 GE Healthcare
  • 9.2.4 Sartorius AG
  • 9.2.5 Becton, Dickinson And Company
  • 9.2.6 Danaher Corporation
  • 9.2.7 Eppendorf AG
  • 9.2.8 Lonza
  • 9.2.9 Advanced Instruments
  • 9.2.10 Nova Biomedical
  • 9.2.11 F. Hoffmann-La Roche Ltd